Peter Lin MD, CCFP
Director, Primary Care Initiatives, Canadian Heart Research Centre, North York, OntarioDr. Peter Lin, a primary care physician, is the Director of Primary Care Initiatives at the Canadian Heart Research Centre and has two busy family medicine practices in Toronto. For 7 years, he served as the medical director at the University of Toronto Scarborough Health & Wellness Centre. In 2011, he received a teaching award from the College of Family Physicians of Canada.
Dr. Lin has worked with KDIGO (Kidney Disease│Improving Global Outcomes) in an effort to help enhance care for patients with chronic kidney disease. He has been a contributing author to the Canadian Diabetes Guidelines and has served on the editorial board of Pri-Med Institute, which provides education for physicians.
Dr. Lin maintains an active lecture schedule, reflecting his varied medical interests, continuing his focus on bridging the chasm between research and clinical practice.
Disclosures
- Consultant (continuing medical education programs): AstraZeneca; Boehringer Ingelheim; Bayer; Eli Lilly; Amgen; Janssen; Merck; Pfizer; Sanofi; Abbott; HLS Therapeutics
Recent Contributions to PracticeUpdate:
- Benefits of Omega-3 Fatty Acids From Fish Oil After Acute MI
- Statins Not Proven to Have Adverse Cognitive Effects
- Medical Considerations Before International Travel
- Improving the Diagnosis and Treatment of UTI in Young Children in Primary Care
- PCI Questionable for Patients With Stable Ischemic Heart Disease
- Prolonged Dual Antiplatelet Therapy in Patients With Stable Coronary Disease
- Evaluation of Dose-Reduced Direct Oral Anticoagulant Therapy
- T2DM Remission Rates After Laparoscopic Gastric Bypass vs Gastric Banding
- LDL Levels and Major Adverse Cardiac Events in Ischemic Heart Disease Treated With Statins
- Empagliflozin Slows Progression of Kidney Disease in Diabetes